$3.28
3.47% yesterday
Nasdaq, Dec 24, 07:00 pm CET
ISIN
US82024L1035
Symbol
STTK

Shattuck Labs Inc Stock price

$3.28
+1.22 59.22% 1M
+2.25 216.91% 6M
+2.07 171.07% YTD
+2.17 195.50% 1Y
+0.87 36.10% 3Y
-54.33 94.31% 5Y
-13.72 80.71% 10Y
-13.72 80.71% 20Y
Nasdaq, Closing price Wed, Dec 24 2025
+0.11 3.47%
ISIN
US82024L1035
Symbol
STTK
Industry

Key metrics

Basic
Market capitalization
$207.6m
Enterprise Value
$121.4m
Net debt
positive
Cash
$86.1m
Shares outstanding
63.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
207.6 | 169.6
EV/Sales
121.4 | 99.2
EV/FCF
negative
P/B
2.2
Financial Health
Equity Ratio
87.5%
Return on Equity
-94.7%
ROCE
-61.2%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$1.0m | $1.2m
EBITDA
$-54.4m | $-48.7m
EBIT
$-58.1m | $-50.5m
Net Income
$-55.2m | $-49.9m
Free Cash Flow
$-49.5m
Growth (TTM | estimate)
Revenue
-84.5% | -78.6%
EBITDA
28.5% | 36.4%
EBIT
27.3% | 37.1%
Net Income
26.6% | 33.8%
Free Cash Flow
20.9%
Margin (TTM | estimate)
Gross
-
EBITDA
-5,441.5% | -3,976.5%
EBIT
-5,813.7%
Net
-5,521.6% | -4,078.4%
Free Cash Flow
-4,946.3%
More
EPS
$-0.8
FCF per Share
$-0.8
Short interest
1.4%
Employees
44
Rev per Employee
$130.0k
Show more

Is Shattuck Labs Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Shattuck Labs Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Shattuck Labs Inc forecast:

8x Buy
67%
4x Hold
33%

Analyst Opinions

12 Analysts have issued a Shattuck Labs Inc forecast:

Buy
67%
Hold
33%

Financial data from Shattuck Labs Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1 1
84% 84%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 17 17
11% 11%
1,717%
- Research and Development Expense 42 42
38% 38%
4,161%
-54 -54
29% 29%
-5,442%
- Depreciation and Amortization 3.72 3.72
4% 4%
372%
EBIT (Operating Income) EBIT -58 -58
27% 27%
-5,814%
Net Profit -55 -55
27% 27%
-5,522%

In millions USD.

Don't miss a Thing! We will send you all news about Shattuck Labs Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Shattuck Labs Inc Stock News

Neutral
GlobeNewsWire
10 days ago
AUSTIN, TX and DURHAM, NC, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-mediated diseases, today announced that it has granted induceme...
Neutral
GlobeNewsWire
about one month ago
AUSTIN, TX and DURHAM, NC, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-mediated diseases, today announced that Company management will...
Neutral
GlobeNewsWire
about 2 months ago
–First participants dosed in Phase 1 clinical trial of SL-325 in healthy volunteers – – Closed a private placement of up to $103 million in August 2025 to support advancement of SL-325 – – Appointments of Dan Baker, M.D., and Mona Ashiya, Ph.D.
More Shattuck Labs Inc News

Company Profile

Shattuck Labs, Inc. engages in the research and development of Agonist Redirected Checkpoint (ARC) platform. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.

Head office United States
CEO Taylor Schreiber
Employees 44
Founded 2016
Website www.shattucklabs.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today